Premium
SC1 sustains the self‐renewal capacity and pluripotency of chicken blastodermal cells by inhibiting the phosphorylation of ERK1 and promoting the phosphorylation of Akt
Author(s) -
Li Rongyang,
Tang Xiaochuan,
Xu Shiyong,
Chen Qing,
Chen Baobao,
Liu Shuo,
Li Bojiang,
Li Weijian,
Yao Yilong,
Wu Wangjun,
Liu Honglin
Publication year - 2018
Publication title -
reproduction in domestic animals
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.546
H-Index - 66
eISSN - 1439-0531
pISSN - 0936-6768
DOI - 10.1111/rda.13202
Subject(s) - phosphorylation , microbiology and biotechnology , stem cell , induced pluripotent stem cell , biology , embryonic stem cell , protein kinase b , pi3k/akt/mtor pathway , signal transduction , genetics , gene
Abstract Small molecules discovered during the recent years can be used to regulate the growth of embryonic stem cells (ES cells). Chicken blastodermal cells (cBCs) play an important role in both basic and transgenic researches as an important ES cell. However, the regulatory mechanism of small molecules involved in the self‐renewal and pluripotency of cBCs remains unknown. This study revealed that the small molecule, SC1, can maintain cBCs in an undifferentiated, pluripotent state in serum‐ and feeder‐free E8 media without leukaemia inhibitory factor. Furthermore, SC1 inhibits downregulation of pluripotency‐related genes caused by retinoic acid and promotes the proliferation of cBCs. Furthermore, the results of this study indicated that SC1 functions by inhibiting ERK1 phosphorylation and promoting Akt phosphorylation, thus promoting the expression of pluripotency‐related genes and maintaining the pluripotency of cBCs. The results also demonstrated that SC1 sustains the self‐renewal capacity and pluripotency of cBCs cells by inhibiting ERK1 phosphorylation and promoting Akt phosphorylation. This kind of regulatory mechanism might be conserved in avian ES cells. Other molecules, similar to SC1, might provide insights into the molecular mechanisms that control the fate of stem cells and ultimately help in‐vivo stem cell biology and therapy.